Effect of low-dose aspirin combined with metoprolol in high blood coagulation and cardiac function of elderly patients with heart failure
10.3969/j.issn.1005-1678.2017.01.076
- VernacularTitle:小剂量阿司匹林结合美托洛尔对老年心衰患者血液高凝及心功能的改善作用
- Author:
Xiaoping GE
;
Jun YANG
- Keywords:
aspirin;
combined;
metoprolol;
elderly patients with heart failure;
high blood coagulation;
cardiac function;
improvement role
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(1):254-256
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the improvement role of low-dose aspirin combined with metoprolol in high blood coagulation and cardiac function of elderly patients with heart failure. Methods 112 cases of elderly patients with heart failure who were treated in our hospital from February 2014 to February 2016 were selected, these patients were randomly divided into conventional therapy group and combined treatment group (conventional therapy combined with low-dose aspirin beauty metoprolol treatment group) two groups, 56 cases in each group. Conventional therapy group was given routine treatment, combined treatment group wered treated on the basis of conventional therapy combined with metoprolol in the treatment of low-dose of aspirin. The plasma P-selectin, VWF, DD, BNP levels, HR, LVEDV, LVEF and clinical efficacy of the two groups were statistically analyzed. Results The P-selectin, VWF, DD, BNP levels of the combined treatment group were significantly lower than those in the conventional treatment group, the difference was statistically significant (P<0.05), the total treatment effective rate 89.3% (50/56) was significantly higher than the conventional therapy group 78.6% (44/56), the difference was statistically significant (P<0.05), but there was no significant difference between the two groups in HR, LVEDV, and LVEF. Conclusion Low-dose aspirin combined with metoprolol can improve the high blood coagulation and cardiac function of elderly patients with heart failure.
